Control-IQ Technology
Interoperable Automated Glycemic Controller. De Novo DEN190034, from Tandem Diabetes Care, Inc. (San Diego, CA). Product code QJI, class 2.
As of Nov 20, 2026, DEN190034 is an FDA De Novo held by Tandem Diabetes Care, Inc., granted on Dec 13, 2019 after 151 days, with no recalls tied to it in FDA's recall database.
- Review time: 151 days
- Recalls: 0
- Cited as a predicate by: 2 devices
Control-IQ technology is intended for use with compatible integrated continuous glucose monitors (iCGM) and alternate controller enabled (ACE) pumps to automatically increase, decrease, and suspend delivery of basal insulin based on iCGM readings and predicted glucose values. It can also deliver correction boluses when the glucose value is predicted to exceed a predefined threshold.
- Design
- Randomized controlled, prospective, multicenter trial, 2:1 Control-IQ vs. sensor-augmented pump (SAP), 6 months
- Enrolled
- 168
- Where
- 7 sites, US
- Control-IQ TechnologyK200467 · Tandem Diabetes Care, Inc. · Jun 16, 2020
- Basal-IQ TechnologyK193483 · Tandem Diabetes Care, Inc. · Feb 28, 2020
- twiist Loop AlgorithmK262576 · Deka Research and Development Corp. · Oct 15, 2026
- iOS CamAPS FXK261896 · CamDiab · Sep 16, 2026
- iLet Dosing Decision SoftwareK262763 · Beta Bionics, Inc. · Sep 11, 2026
- SmartGuard Technology; Predictive Low Glucose TechnologyK261962 · Medtronic MiniMed · Jul 9, 2026
- Omnipod 6 algorithmK261461 · Insulet Corporation · Jun 29, 2026
- Control-IQ+ technologyK260429 · Tandem Diabetes Care, Inc. · Apr 24, 2026
- SmartGuard Technology; Predictive Low Glucose TechnologyK253701 · Medtronic Minimed · Feb 3, 2026
- SmartGuard technology; Predictive Low Glucose technologyK253585 · Medtronic Minimed, Inc. · Jan 14, 2026
- Document
- De Novo decision summary (PDF) ↗
- Type
- Direct
- Received
- Jul 15, 2019
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1356
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files